公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor | LIH-CHING HSU ; Durrant D.E.; Huang C.-C.; Chi N.-W.; Baruchello R.; Rondanin R.; Rullo C.; Marchetti P.; Grisolia G.; Simoni D.; Lee R.M. | Investigational New Drugs | 14 | 10 | |
2016 | Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth | Lai W.-T.; Cheng K.-L.; Baruchello R.; Rondanin R.; Marchetti P.; Simoni D.; Lee R.M.; JIH-HWA GUH ; LIH-CHING HSU | Biochemical Pharmacology | 7 | 7 | |
2004 | The HPV16 E6/E7 oncogene sensitizes human ovarian surface epithelial cells to low-dose but not high-dose 5-FU and 5-FUdR | LIH-CHING HSU ; Lee R.M.; White R.L. | Biochemical and Biophysical Research Communications | 4 | 4 | |
2016 | A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach | Marchetti P.; Pavan B.; Simoni D.; Baruchello R.; Rondanin R.; Mischiati C.; Feriotto G.; Ferraro L.; LIH-CHING HSU ; Lee R.M.; Dalpiaz A. | European Journal of Pharmaceutical Sciences | 8 | 8 |